Notably, clinical metadata analyses in this study validate that low expression of CDC73 is associated with poor relapse free survival of breast cancer patients, as well as decreased levels of tumor-infiltrating CD8+ T cells. This evidence concerns the gene CDC73 and breast carcinoma.